Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.

Source:http://linkedlifedata.com/resource/pubmed/id/15870090

Download in:

View as

General Info

PMID
15870090